Welcome to our dedicated page for e.l.f. Beauty SEC filings (Ticker: ELF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
e.l.f. Beauty, Inc. SEC filings document the public-company record for its NYSE-listed common stock and multi-brand beauty operations. The company’s Form 8-K filings report operating and financial results, material events, material agreements, capital-structure disclosures and board-level governance changes.
Proxy materials provide disclosure on shareholder voting matters, director elections, executive compensation, equity awards and governance practices. The filings connect these formal disclosures to e.l.f. Beauty’s operating model across cosmetics, skin care and related beauty brands, while documenting the company’s reporting obligations, security registration and corporate oversight structure.
Form 144 notice for e.l.f. Beauty, Inc. (ELF) reports a proposed sale of 785 restricted common shares by the named person through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $100,792.59 and an approximate sale date of 08/28/2025. The shares were acquired as restricted stock on 08/22/2024 and payment was recorded as not applicable.
The filing also discloses a prior sale by Maureen C. Watson of 3,875 common shares on 06/03/2025 generating gross proceeds of $445,625.00. The filer certifies no undisclosed material adverse information and includes the standard Rule 144 representations.
Form 144 notice for e.l.f. Beauty, Inc. (ELF): The filer proposes to sell 565 shares of common stock through Morgan Stanley Smith Barney (New York) on 08/28/2025 with an aggregate market value of $73,563.00. The issuer reports 56,734,903 shares outstanding. The securities were acquired as restricted stock on 08/22/2025 from the issuer and payment is recorded on 08/22/2025. The filer reports “Nothing to Report” for sales during the past three months and certifies no undisclosed material adverse information is known.
e.l.f. Beauty, Inc. (ELF) director received a grant of restricted stock units. The Form 4 filed for reporting person Gayle Tait shows a grant of 1,633 RSUs on 08/21/2025. Each RSU converts into one share when vested; the transaction price is reported as $0. After the reported grant, the filing shows the reporting person beneficially owns 5,767 shares in total. The filing is signed by an attorney-in-fact on behalf of Gayle Tait on 08/25/2025. The reporting person is identified as a director of the issuer.
Charles V. Bergh, a director of e.l.f. Beauty, Inc. (ELF), received a grant of 1,203 restricted stock units (RSUs) on 08/21/2025. Each RSU converts to one share upon vesting, and the reported transaction shows 1,203 RSUs acquired at a reported price of $0. After the grant, Mr. Bergh’s total beneficial ownership is reported as 2,056 shares (which includes the 1,203 RSUs). The Form 4 was signed by an attorney-in-fact on behalf of Mr. Bergh on 08/25/2025. This filing discloses a routine equity compensation award to a director and does not include exercise prices or vesting schedule details in the submitted content.
e.l.f. Beauty, Inc. (ELF) Form 4 disclosure: This filing reports a grant of 1,203 restricted stock units (RSUs) to Maria Ferreras, who is identified as a director of the company. Each RSU converts into one share of common stock upon vesting and the RSUs were reported with a transaction date of 08/21/2025 and zero cash price. After the reported transaction, the filing shows the reporting person beneficially owns 2,024 shares in total, which includes the 1,203 RSUs. The Form 4 was signed by an attorney-in-fact on behalf of Ms. Ferreras and is a routine insider reporting of equity compensation.
e.l.f. Beauty director Kenneth Mitchell received a grant of 1,676 restricted stock units (RSUs) on 08/21/2025. Each RSU converts to one share upon vesting and the reported grant was recorded with a $0 purchase price, indicating compensation rather than a cash purchase. After the award, the reporting person beneficially owns 17,847 shares in total. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Mitchell on 08/25/2025 and lists his role as a director. The filing documents a routine equity compensation award to an insider and does not disclose vesting dates or additional terms for the RSUs.
e.l.f. Beauty director Lori Keith received a grant of 1,680 restricted stock units (RSUs) on 08/21/2025, each converting into one share upon vesting. The Form 4 shows the acquisition was reported as a non‑derivative transaction with a reported price of $0, and the reporting person's total beneficial ownership following the grant is 22,698 shares (which includes the 1,680 RSUs). The filing identifies Lori Keith as a director and was signed by an attorney‑in‑fact on 08/25/2025.
e.l.f. Beauty, Inc. insider report: Director Lauren Cooks Levitan was granted 1,203 restricted stock units (RSUs) on 08/21/2025. Each RSU converts to one share of common stock upon vesting, and the grant is reported at no cash price. After the grant, the reporting person’s total beneficial ownership is reported as 12,710 shares, which the filing notes includes the 1,203 RSUs. The transaction is recorded as an acquisition of equity compensation rather than an open-market purchase or sale.
The reporting person, Tiffany F. Daniele, a director of e.l.f. Beauty, Inc. (ELF), was granted 1,203 restricted stock units (RSUs) on 08/21/2025 that vest into one share per RSU. The reported transaction was recorded as an acquisition at no cash price, and after the grant the reporting person beneficially owns 6,837 shares (which includes the 1,203 RSUs).
The Form 4 was filed individually and signed by an attorney-in-fact on behalf of the reporting person. The filing discloses only the RSU grant and does not include any derivative transactions, cash purchases, sales, exercise activity, or additional details about vesting schedule or restrictions.
Maureen C. Watson, a director of e.l.f. Beauty, Inc. (ELF), was granted 1,642 restricted stock units (RSUs) on 08/21/2025. Each RSU converts into one share of common stock upon vesting, and the reported acquisition price is $0, indicating these were awards rather than open-market purchases. After the grant, the reporting person is shown as beneficially owning 3,530 shares in total, which the filer states includes the 1,642 RSUs. The Form 4 was signed by an attorney-in-fact for Maureen Watson on 08/25/2025. The filing identifies the reporting person as a director.